CRISTINA SARROSA: Open Payments
NPI 1376097261 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,825 in 97 payments from 20 companies in 2025. Trend: 2023 $1,040 · 2024 $1,560 · 2025 $1,825
Food & beverage: $1,825
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $281 |
| AstraZeneca Pharmaceuticals LP | 11 | $273 |
| Novo Nordisk Inc | 11 | $209 |
| Amgen Inc. | 12 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $147 |
| Lilly USA, LLC | 8 | $147 |
| Ardelyx, Inc. | 5 | $102 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
| Daiichi Sankyo Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 4 | $60 |
Products named: NURTEC ODT, AIRSUPRA, Kerendia, FARXIGA, IBSRELA, EVENITY, GEMTESA, PREVNAR 20.
Industry payments across OK — which companies pay providers there.
